List of molecules and drugs that target protein P42262

#	DrugDomain Data	DrugBank Accession	Name	Drug action	Affinity data	InChI Key	SMILES
1	P42262_DB00142	DB00142	Glutamic acid	n/a	Ki(nM) = 940.0 EC50(nM) = 2190.0	WHUUTDBJXJRKMK-VKHMYHEASA-N	N[C@@H](CCC(O)=O)C(O)=O
2	P42262_DB00237	DB00237	Butabarbital	antagonist		ZRIHAIZYIMGOAB-UHFFFAOYSA-N	CCC(C)C1(CC)C(=O)NC(=O)NC1=O
3	P42262_DB00241	DB00241	Butalbital	antagonist		UZVHFVZFNXBMQJ-UHFFFAOYSA-N	CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
4	P42262_DB00306	DB00306	Talbutal	antagonist		BJVVMKUXKQHWJK-UHFFFAOYSA-N	CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
5	P42262_DB00312	DB00312	Pentobarbital	antagonist		WEXRUCMBJFQVBZ-UHFFFAOYSA-N	CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
6	P42262_DB00418	DB00418	Secobarbital	antagonist		KQPKPCNLIDLUMF-UHFFFAOYSA-N	CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
7	P42262_DB00463	DB00463	Metharbital	antagonist		FWJKNZONDWOGMI-UHFFFAOYSA-N	CCC1(CC)C(=O)NC(=O)N(C)C1=O
8	P42262_DB00599	DB00599	Thiopental	antagonist		IUJDSEJGGMCXSG-UHFFFAOYSA-N	CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
9	P42262_DB00794	DB00794	Primidone	antagonist		DQMZLTXERSFNPB-UHFFFAOYSA-N	CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
10	P42262_DB00849	DB00849	Methylphenobarbital	antagonist		ALARQZQTBTVLJV-UHFFFAOYSA-N	CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1
11	P42262_DB00898	DB00898	Ethanol	n/a		LFQSCWFLJHTTHZ-UHFFFAOYSA-N	CCO
12	P42262_DB01174	DB01174	Phenobarbital	antagonist		DDBREPKUVSBGFI-UHFFFAOYSA-N	CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
13	P42262_DB01346	DB01346	Quinidine barbiturate	antagonist		YHRUERMOPBDCFD-UHFFFAOYSA-N	CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1.COC1=CC2=C(C=CN=C2C=C1)C(O)C1CC2CCN1CC2C=C
14	P42262_DB01351	DB01351	Amobarbital	antagonist		VIROVYVQCGLCII-UHFFFAOYSA-N	CCC1(CCC(C)C)C(=O)NC(=O)NC1=O
15	P42262_DB01352	DB01352	Aprobarbital	antagonist		UORJNBVJVRLXMQ-UHFFFAOYSA-N	CC(C)C1(CC=C)C(=O)NC(=O)NC1=O
16	P42262_DB01353	DB01353	Butobarbital	antagonist		STDBAQMTJLUMFW-UHFFFAOYSA-N	CCCCC1(CC)C(=O)NC(=O)NC1=O
17	P42262_DB01354	DB01354	Heptabarbital	antagonist		PAZQYDJGLKSCSI-UHFFFAOYSA-N	CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1
18	P42262_DB01355	DB01355	Hexobarbital	antagonist		UYXAWHWODHRRMR-UHFFFAOYSA-N	CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1
19	P42262_DB01483	DB01483	Barbital	antagonist		FTOAOBMCPZCFFF-UHFFFAOYSA-N	CCC1(CC)C(=O)NC(=O)NC1=O
20	P42262_DB01496	DB01496	Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione	antagonist		DNZPLHRZXUJATK-UHFFFAOYSA-N	FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1
21	P42262_DB01664	DB01664	(S)-DES-ME-AMPA	n/a		ZKLGQYGPVBFAQQ-BYPYZUCNSA-N	N[C@@H](CC1=CONC1=O)C(O)=O
22	P42262_DB02057	DB02057	(S)-AMPA	n/a		UUDAMDVQRQNNHZ-YFKPBYRVSA-N	CC1=C(C[C@H](N)C(O)=O)C(O)=NO1
23	P42262_DB02347	DB02347	2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid	n/a		AGSOOCUNMTYPSE-ZETCQYMHSA-N	CC(C)(C)C1=C(C[C@H](N)C(O)=O)C(OCP(O)(O)=O)=NO1
24	P42262_DB02818	DB02818	Iodo-Willardiine	n/a	Ki(nM) = 176.0	AXXYLTBQIQBTES-BYPYZUCNSA-N	N[C@@H](CN1C=C(I)C(=O)NC1=O)C(O)=O
25	P42262_DB02966	DB02966	Fluoro-Willardiine	n/a	Ki(nM) = 25.0 EC50(nM) = 463.0	DBWPFHJYSTVBCZ-BYPYZUCNSA-N	N[C@@H](CN1C=C(F)C(=O)NC1=O)C(O)=O
26	P42262_DB02999	DB02999	Quisqualic acid	n/a		ASNFTDCKZKHJSW-REOHCLBHSA-N	N[C@@H](CN1OC(=O)NC1=O)C(O)=O
27	P42262_DB03240	DB03240	(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid	n/a		VSGUEKZRMJVQOH-LURJTMIESA-N	N[C@@H](CN1C2=C(CCC2)C(=O)NC1=O)C(O)=O
28	P42262_DB03319	DB03319	(2S)-2-Ammonio-3-[5-(2-methyl-2-propanyl)-3-oxido-1,2-oxazol-4-yl]propanoate	n/a		PIXJURSCCVBKRF-LURJTMIESA-M	[H][C@](N)(CC1=C(ON=C1[O-])C(C)(C)C)C(O)=O
29	P42262_DB03759	DB03759	FG-9041	n/a		RWVIMCIPOAXUDG-UHFFFAOYSA-N	[O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)[N+]([O-])=O
30	P42262_DB04000	DB04000	Bromo-Willardiine	n/a	Ki(nM) = 101.0	AEKIJKSVXKWGRJ-BYPYZUCNSA-N	N[C@@H](CN1C=C(Br)C(=O)NC1=O)C(O)=O
31	P42262_DB04129	DB04129	Willardiine	n/a	Ki(nM) = 898.0	KCGPSMHZJWSWPT-UHFFFAOYSA-N	NOC(=O)CCN1C=CC(=O)NC1=O
32	P42262_DB04152	DB04152	2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid	n/a		HJEPOXZLPHUVFE-ZETCQYMHSA-N	N[C@@H](CC1=CCCCC2=C1C(=O)NO2)C(O)=O
33	P42262_DB04599	DB04599	Aniracetam	n/a		ZXNRTKGTQJPIJK-UHFFFAOYSA-N	COC1=CC=C(C=C1)C(=O)N1CCCC1=O
34	P42262_DB04798	DB04798	THIO-ATPA	n/a		FHWOAQCPEFTDOQ-LURJTMIESA-N	[H][C@]([NH3+])(CC1=C(SN=C1[O-])C(C)(C)C)C(O)=O
35	P42262_DB04982	DB04982	Talampanel	n/a		JACAAXNEHGBPOQ-LLVKDONJSA-N	C[C@@H]1CC2=CC3=C(OCO3)C=C2C(=NN1C(C)=O)C1=CC=C(N)C=C1
36	P42262_DB05047	DB05047	CX-717	n/a		KFRQROSRKSVROW-UHFFFAOYSA-N	O=C(N1CCOCC1)C1=CC2=NON=C2C=C1
37	P42262_DB07455	DB07455	N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide	n/a		ZESUARCHWPARIF-HOTGVXAUSA-N	[H][C@](C)(CNS(C)(=O)=O)C1=CC=C(C=C1)C1=CC=C(C=C1)[C@@]([H])(C)CNS(C)(=O)=O
38	P42262_DB07598	DB07598	2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE	n/a		RQEPVMAYUINZRE-GFCCVEGCSA-N	[H][C@@]12CCCN1C(=O)C1=C(O2)C=C2OCCOC2=C1
39	P42262_DB08303	DB08303	(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide	n/a		CUMKMTBOHBENJI-SFHVURJKSA-N	[H][C@@]1(NC2=CC(C)=C(C=C2S(=O)(=O)N1)S(=O)(=O)N1CCN(C)CC1)C1CCCC1
40	P42262_DB08304	DB08304	(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide	n/a		QZBQVXXESPXFPZ-QGZVFWFLSA-N	[H][C@@]1(CC2=C(C=C(C=C2)S(=O)(=O)N2CCN(C)CC2)S(=O)(=O)N1)C1CCCC1
41	P42262_DB08305	DB08305	(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide	n/a		KQAGZLQCEURCKJ-QGZVFWFLSA-N	[H][C@@]1(CC2=CC(C)=C(C=C2S(=O)(=O)N1)S(=O)(=O)N1CCN(C)CC1)C1CCCC1
42	P42262_DB13146	DB13146	Fluciclovine (18F)	inhibitor		NTEDWGYJNHZKQW-DGMDOPGDSA-N	N[C@]1(C[C@H]([18F])C1)C(O)=O